Literature DB >> 9149568

Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia.

M J Boldt1, T R Bai.   

Abstract

STUDY
OBJECTIVES: In patients with HIV infection, serum lactate dehydrogenase (LDH) level is commonly stated to be more elevated in Pneumocystis carinii pneumonia (PCP) than in non-PCP. We hypothesized that LDH level reflects radiographic extent and severity of pneumonia rather than P carinii infection specifically and therefore is not useful in the differential diagnosis of lung infections in AIDS.
DESIGN: We compared radiographic features and LDH values in 93 sequential patients with HIV infection and a new hospital admission for pneumonia (53 PCP and 40 non-PCP) after excluding all patients with other potential causes for elevated LDH levels. The chest radiograph was graded using a quantitative scale (0 to 24) to assess radiographic extent and severity of pneumonia by two independent observers in blinded fashion. The relationship between radiographic score and hospital admission LDH level was analyzed by linear regression and Bayesian analysis was applied to different LDH ranges to calculate the clinical value of LDH measurements.
SETTING: Tertiary care teaching hospital and regional AIDS referral center.
RESULTS: Mean LDH level was higher in the PCP group (1.217 +/- 88 U/L compared with 776 +/- 55 U/L; p < 0.001), as was mean radiographic score (12.4 +/- 0.6 for PCP compared with 6.3 +/- 0.5 for non-PCP; p < 0.001). For the whole sample of 93, LDH level was significantly related to chest radiographic score (r = 0.43, p < 0.0001). Significant overlap occurred between the two groups at all levels of LDH such that no cutoff level could be established that impacted significantly on posttest probability of PCP, whereas a radiographic score of > 12 yielded a 96% posttest probability of PCP.
CONCLUSIONS: Serum LDH level reflects the degree of radiographic abnormality and is elevated in both PCP and non-PCP pneumonia to an extent that limits its utility in differentiating the two processes in hospitalized patients. The extent of radiographic involvement more clearly distinguishes the two conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149568     DOI: 10.1378/chest.111.5.1187

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  A Clinically Applicable Nomogram for Predicting the Risk of Invasive Mechanical Ventilation in Pneumocystis jirovecii Pneumonia.

Authors:  Rongjun Wan; Lu Bai; Yusheng Yan; Jianmin Li; Qingkai Luo; Hua Huang; Lingmei Huang; Zhi Xiang; Qing Luo; Zi Gu; Qing Guo; Pinhua Pan; Rongli Lu; Yimin Fang; Chengping Hu; Juan Jiang; Yuanyuan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-03-10       Impact factor: 5.293

2.  Risk factors of in-hospital mortality in patients with pneumocystis pneumonia diagnosed by metagenomics next-generation sequencing.

Authors:  Jun-Na Hou; Heng-Dao Liu; Qiu-Yue Tan; Feng-An Cao; Shi-Lei Wang; Meng-Ying Yao; Yang-Chao Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-09-26       Impact factor: 6.073

3.  Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: a prospective, cohort study.

Authors:  B Afessa
Journal:  BMC Pulm Med       Date:  2001       Impact factor: 3.317

4.  Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.

Authors:  Julius J Schmidt; Catherina Lueck; Stefan Ziesing; Matthias Stoll; Hermann Haller; Jens Gottlieb; Matthias Eder; Tobias Welte; Marius M Hoeper; André Scherag; Sascha David
Journal:  Crit Care       Date:  2018-11-19       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.